O. Driessen

558 total citations
47 papers, 466 citations indexed

About

O. Driessen is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, O. Driessen has authored 47 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pediatrics, Perinatology and Child Health, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in O. Driessen's work include Pharmacological Effects and Toxicity Studies (10 papers), Pharmaceutical studies and practices (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). O. Driessen is often cited by papers focused on Pharmacological Effects and Toxicity Studies (10 papers), Pharmaceutical studies and practices (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). O. Driessen collaborates with scholars based in Netherlands, Belgium and United Kingdom. O. Driessen's co-authors include Marc Michel, K. F. Kerrebijn, E. A. de Bruijn, A. M. Horrevorts, G.R. Mohn, J. W. A. Meijer, Johan Lugtenburg, C.W. Thesingh, D. De Vos and Gerrit Lodder and has published in prestigious journals such as CHEST Journal, Journal of Chromatography A and International Journal of Cancer.

In The Last Decade

O. Driessen

45 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
O. Driessen Netherlands	14	117	101	80	70	70	47	466
Dulal C. Chatterji United States	14	91 0.8×	140 1.4×	131 1.6×	42 0.6×	45 0.6×	31	563
Alfred E. Staubus United States	17	68 0.6×	103 1.0×	144 1.8×	56 0.8×	64 0.9×	41	786
S M Kalman United States	12	48 0.4×	128 1.3×	155 1.9×	37 0.5×	59 0.8×	17	532
David G. Parsons United States	9	140 1.2×	49 0.5×	82 1.0×	46 0.7×	15 0.2×	27	626
Minoru Aoki Japan	15	151 1.3×	37 0.4×	182 2.3×	22 0.3×	57 0.8×	75	730
Milan Lázníček Czechia	15	98 0.8×	235 2.3×	141 1.8×	33 0.5×	51 0.7×	68	713
Hiroshi Ohe Japan	16	316 2.7×	46 0.5×	88 1.1×	45 0.6×	21 0.3×	53	690
Marc Galtier France	11	44 0.4×	132 1.3×	92 1.1×	92 1.3×	42 0.6×	19	470
Andrea Leone‐Bay United States	20	104 0.9×	111 1.1×	282 3.5×	62 0.9×	42 0.6×	43	1.0k
Marie L. Smith United Kingdom	15	58 0.5×	80 0.8×	164 2.0×	43 0.6×	31 0.4×	44	586

Countries citing papers authored by O. Driessen

Since Specialization

Citations

This map shows the geographic impact of O. Driessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Driessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Driessen more than expected).

Fields of papers citing papers by O. Driessen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Driessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Driessen. The network helps show where O. Driessen may publish in the future.

Co-authorship network of co-authors of O. Driessen

This figure shows the co-authorship network connecting the top 25 collaborators of O. Driessen. A scholar is included among the top collaborators of O. Driessen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Driessen. O. Driessen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Driessen, O., Martin Highley, Peter Harper, R. A. A. Maes, & E. A. de Bruijn. (1994). Description of an instrument for separation of red cells from plasma and measurement of red cell volume. Clinical Biochemistry. 27(3). 195–196. 18 indexed citations

Bruijn, E. A. de, Yi Geng, J. Hermans, & O. Driessen. (1990). The CMF‐regimen. Modulation of cyclophosphamide uptake and clearance by methotrexate and fluorouracil. International Journal of Cancer. 45(5). 935–939. 7 indexed citations

Driessen, O., et al.. (1989). Distribution of Drugs over Whole Blood. Therapeutic Drug Monitoring. 11(4). 390–400. 10 indexed citations

Horrevorts, A. M., J. E. Degener, Wim C.J. Hop, et al.. (1987). Tobramycin in Patients with Cystic Fibrosis. CHEST Journal. 92(5). 844–848. 24 indexed citations

Driessen, O., et al.. (1987). The Stability of 5,6-Dihydrofluorouracil in Plasma and the Consequences for Its Analysis. Therapeutic Drug Monitoring. 9(4). 443–447. 11 indexed citations

Driessen, O., et al.. (1985). Does determination of polyamines in body fluids require heating with hydrochloric acid?. PubMed. 7(10). 535–8. 1 indexed citations

Driessen, O., et al.. (1984). Influence of Intralipid infusion on the elimination of phenytoin.. PubMed. 267(2). 180–6. 16 indexed citations

Bonnet, J., et al.. (1983). Gas chromatography judged by optic fibre techniques. Journal of Chromatography A. 279. 476–482. 1 indexed citations

Bruijn, E. A. de, O. Driessen, E van Strijen, et al.. (1983). A gas chromatographic assay for the determination of 5,6-dihydrofluorouracil and 5-fluorouracil in human plasma. PubMed. 278(2). 283–289. 23 indexed citations

10.

Natarajan, A.T., et al.. (1983). Induction of chromosomal alterations as an assay for cytostatic drug activity in plasma. Mutation Research Letters. 121(1). 39–45. 14 indexed citations

11.

Driessen, O., et al.. (1980). Adsorption of [¹⁴C] phenytoin in a gas chromatographic system. Journal of High Resolution Chromatography. 3(2). 62–68. 2 indexed citations

12.

Driessen, O., et al.. (1979). Variability and predictability of the plasma concentration of ampicillin and kanamycin in new-born infants. European Journal of Clinical Pharmacology. 15(2). 133–137. 4 indexed citations

13.

Thesingh, C.W., O. Driessen, Walter Daems, et al.. (1978). Accumulation and localization of gallium-67 in various types of primary lung carcinoma.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 19(1). 28–30. 16 indexed citations

14.

Driessen, O., et al.. (1978). Treatment of Theophylline Intoxication: A Model Study Utilizing Peritoneal Dialysis. Clinical toxicology. 13(4). 505–511. 7 indexed citations

15.

Driessen, O., et al.. (1978). Adsorption of Fluorouracil on Glass Surfaces. Journal of Pharmaceutical Sciences. 67(10). 1494–1495. 13 indexed citations

16.

Driessen, O., et al.. (1978). Pharmacokinetic aspects of therapy with ampicillin and kanamycin in new-born infants. European Journal of Clinical Pharmacology. 13(6). 449–457. 13 indexed citations

17.

Driessen, O., et al.. (1976). Autoradiographic model experiments with 67Ga and 99mTc. Histochemistry and Cell Biology. 50(1). 77–80. 4 indexed citations

18.

Hermans, J., et al.. (1975). Pharmacokinetic analysis of ampicillin concentration in neonates: comparison of two pharmacokinetic models and of two numerical methods.. PubMed. 25(6). 947–9. 4 indexed citations

19.

Driessen, O. & E. L. Noach. (1968). Effect of testosterone propionate on the renal excretion of iodide-131 in the rat. European Journal of Pharmacology. 3(3). 257–262.

20.

Driessen, O., P.A. Voûte, & A. Vermeulen. (1968). A DESCRIPTION OF TWO BROTHERS WITH PERMANENTLY RAISED NON-ESTERIFIED AETIOCHOLANOLONE BLOOD LEVEL. European Journal of Endocrinology. 57(2). 177–186. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact